Table 4 Preoperative markers, bcl-2 and cathepsin–L serum concentrations depending on response to chemotherapy
S | IS | p | S | R | p | IS | R | p | S | IS+R | p | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CA125 [IU/ml] | p = 0.038 | p = 0.1852 | p = 0.2261 | p = 0.0324 | ||||||||
Median | 575.77 | 1338.79 | 575.77 | 949.01 | 1338.79 | 949.01 | 575.77 | 1058.15 | ||||
Range | (7.38-2743.5) | (464.43-4882.06) | (7.38-2743.5) | (49.23-22982) | (464.43-4882.06) | (49.23-22982) | (7.38-2743.5) | (49.23-22982) | ||||
HE4 [pmol/l] | p = 0.045 | p = 0.268 | p = 0.127 | p = 0.0888 | ||||||||
Median | 254.42 | 566.22 | 254.42 | 271.32 | 566.22 | 271.32 | 254.42 | 349.96 | ||||
Range | (2.5-1310.69) | (106.96-1574.89) | (2.5-1310.69) | (2.5-590.13) | (106.96-1574.89) | (2.5-590.13) | (2.5-1310.69) | (2.5-1574.89) | ||||
YKL-40 [ng/ml] | p = 0.062 | 0 = 0.0218 | p = 0.2452 | p = 0.0339 | ||||||||
Median | 131.04 | 143.55 | 131.04 | 231.02 | 143.55 | 231.02 | 131.04 | 193.53 | ||||
Range | (16.42-417.27) | (55.06-235.01) | (16.42-417.27) | (63.98-437.01) | (55.06-235.01) | (63.98-437.01) | (16.42-417.27) | (55.06-437.01) | ||||
Cathepsin-L [ng/ml] | p = 0.3242 | p = 0.1734 | p = 0.2759 | p = 0.3461 | ||||||||
Median | 12.72 | 12.26 | 12.72 | 11.68 | 12.26 | 11.68 | 12.72 | 11.84 | ||||
Range | (8.42-46.45) | (9.74-14.98) | (8.42-46.45) | (9.34-18.17) | (9.74-14.98) | (9.34-18.17) | (8.42-46.45) | (9.34-18.17) | ||||
bcl-2 [ng/ml] | p = 0.1010 | p = 0.0719 | p = 0.1073 | p = 0.2777 | ||||||||
Median | 24.37 | 32.48 | 24.37 | 16.73 | 32.48 | 16.73 | 24.37 | 20.84 | ||||
Range | (18.91-29.84) | (9.89-81.02) | (18.91-29.84) | (4.88-30.94) | (9.89-81.02) | (4.88-30.94) | (18.91-29.84) | (4.88-81.02) |